Metabolic Regulation Investigation of its potential role in modulating glucose metabolism and energy homeostasis in preclinical models
Endocrine (2016) 53:10716
This suggests semaglutide doesnt seem to increase the risk of anxiety or other mood issues
T2DM = type 2 diabetes mellitus dIncludes chronic gastritis, gastritis, gastritis erosive, and reflux gastritis eIncludes paresthesia, hyperesthesia, burning sensation, allodynia, dysesthesia, skin burning sensation, pain of skin, and sensitive skin In a cardiovascular outcomes trial, 8,803 patients were exposed to WEGOVY for a median of 37.3 months and 8,801 patients were exposed to placebo for a median of 38.6 months [see Clinical Studies (14.1)]